
Let’s be honest: Strategy often gets blamed for bad outcomes it had nothing to do with. It’s not the strategy’s fault you missed the competitor’s surprise product drop, or that you priced for last year’s market dynamics, or that you completely whiffed on that new entrant scaling quietly in the background. The strategy didn’t fail.…

Picture this: You’re in a high-stakes chess match. The room is silent. The tension is thick. Every move counts. But instead of thinking ahead, you’re fixated on where your opponent used to be five turns ago. You can guess what happens next—you lose. Not because you’re not smart. But because you’re not paying attention to…

Competitive intelligence in biotech and pharma isn’t just about tracking pipeline developments—it’s a high-stakes game where missing a key move can cost billions. Yet, time and again, companies fail to anticipate threats because they focus only on obvious competitors, outdated playbooks, or conventional industry players. It’s like preparing for a well-known rival in a championship…

A Preview of My Upcoming Talk: Presenting Pricing Insights That Resonate with Leaders Pricing strategies often rely on robust data—carefully researched, meticulously analyzed, and expertly compiled. Yet, even the most data-driven pricing recommendations can be met with hesitation, skepticism, or outright dismissal when presented to executives. Why? Because pricing isn’t just about the numbers; it’s…

If Moneyball taught us anything, it’s that numbers don’t always tell the full story. Sure, a batting average can tell you how often a player gets on base, but it won’t tell you if they thrive under pressure or fall apart in big moments. The same is true for Voice of the Customer (VoC) data.…

Introduction Background Drug pricing reform in the U.S., driven by legislative changes such as the Inflation Reduction Act (IRA) and ongoing policy initiatives, is set to significantly alter the pharmaceutical competitive landscape. These changes will influence market access, pricing strategies, reimbursement dynamics, and competitive positioning. This white paper explores the key impacts of drug pricing…

After spending two decades in the pharmaceutical industry, I’ve seen companies struggle to stay ahead of competitors, anticipate market shifts, and adapt to unexpected threats. Just like football, the industry is a high-stakes, fast-moving game, where misreading the competition or failing to anticipate the next play can cost you the championship. I’ve worked with organizations…

Competitive Intelligence (CI) professionals often find themselves in a paradox: the more seamlessly we integrate insights into decision-making, the less visible our value can seem. It’s the CI equivalent of being the stagehand who moves props perfectly—no one notices unless something goes wrong. But in our current world, “invisible value” just won’t cut it. Decision-makers…

After nearly three decades in customer insights, I’ve seen far too many companies invest in Voice of the Customer (VoC) programs only to be frustrated by the lack of tangible results. You collect feedback, analyze data, and track Net Promoter Scores (NPS), but somehow, customer retention rates remain flat, complaints persist, and leadership starts questioning…
















When critical decisions carry meaningful business implications, our team helps leaders move forward with greater clarity and confidence.
